NEW YORK (GenomeWeb News) - Ohio State University will make available a SELDI-based hematology test made by Vermillion, the company said today.
 
Vermillion, formerly known as Ciphergen, said OSU will license the homebrew test for managing patients with the blood-clotting disorder thrombotic thrombocytopenic purpura. The test was co-developed with the school’s University Research Foundation.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.